{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:34:32Z","timestamp":1761561272711},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Structural Biology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.sbi.2008.07.006","type":"journal-article","created":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T14:21:02Z","timestamp":1220538062000},"page":"558-566","source":"Crossref","is-referenced-by-count":25,"title":["Disease-associated carbohydrate-recognising proteins and structure-based inhibitor design"],"prefix":"10.1016","volume":"18","author":[{"given":"Mark","family":"von Itzstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sbi.2008.07.006_bib1_1","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.1136611","article-title":"Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis","volume":"315","author":"Lovering","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.sbi.2008.07.006_bib2","doi-asserted-by":"crossref","first-page":"9973","DOI":"10.1074\/jbc.M610285200","article-title":"Structure and mechanism of Helicobacter pylori fucosyltransferase. A basis for lipopolysaccharide variation and inhibitor design","volume":"282","author":"Sun","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.sbi.2008.07.006_bib3","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1073\/pnas.0701160104","article-title":"Crystal structure of a peptidoglycan glycosyltransferase suggests a model for processive glycan chain synthesis","volume":"104","author":"Yuan","year":"2007","journal-title":"Proc Nat Acad Sci"},{"key":"10.1016\/j.sbi.2008.07.006_bib4","series-title":"Fact Sheet No. 104","author":"World Health Organisation","year":"2002"},{"key":"10.1016\/j.sbi.2008.07.006_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/glycob\/5.6.547","article-title":"Galactofuranose-containing glycoconjugates in trypanosomatids","volume":"5","author":"de Lederkremer","year":"1995","journal-title":"Glycobiology"},{"key":"10.1016\/j.sbi.2008.07.006_bib6","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1021\/ja7104152","article-title":"Investigation of binding of UDP-Galf and UDP-[3-F]Galf to UDP-galactopyranose mutase by STD-NMR spectroscopy, molecular dynamics, and CORCEMA-ST calculations","volume":"130","author":"Yuan","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.sbi.2008.07.006_bib7","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1021\/ja8018687","article-title":"Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth","volume":"130","author":"Dykhuizen","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.sbi.2008.07.006_bib8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.carres.2007.04.027","article-title":"Synthesis and biological evaluation of galactofuranosyl alkyl thioglycosides as inhibitors of mycobacteria","volume":"342","author":"Davis","year":"2007","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.sbi.2008.07.006_bib9","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.bmcl.2007.01.068","article-title":"Synthesis and evaluation of galactofuranosyl N,N-dialkyl sulfenamides and sulfonamides as antimycobacterial agents","volume":"17","author":"Owen","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.sbi.2008.07.006_bib10_1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pt.2008.02.007","article-title":"Hot, sweet and sticky: the glycobiology of Plasmodium falciparum","volume":"24","author":"von Itzstein","year":"2008","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.sbi.2008.07.006_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/978-1-60327-058-8_33","article-title":"Structural genomics of pathogenic protozoa: an overview","volume":"426","author":"Fan","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.sbi.2008.07.006_bib12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.sbi.2007.08.001","article-title":"Structural biology of plasmodial proteins","volume":"17","author":"Gayathri","year":"2007","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.sbi.2008.07.006_bib13","doi-asserted-by":"crossref","first-page":"13003","DOI":"10.1074\/jbc.M609984200","article-title":"Open and closed structures of the UDP-glucose pyrophosphorylase from Leishmania major","volume":"282","author":"Steiner","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.sbi.2008.07.006_bib14_1","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1002\/anie.200705435","article-title":"A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors","volume":"47","author":"Buchini","year":"2008","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.sbi.2008.07.006_bib15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/pgmj.2006.047357","article-title":"Chagas disease","volume":"82","author":"Teixeira","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.sbi.2008.07.006_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrmicro1351","article-title":"Trypanosoma cruzi surface mucins: host-dependent coat diversity","volume":"4","author":"Buscaglia","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.sbi.2008.07.006_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijantimicag.2005.09.006","article-title":"Current state of three-dimensional characterisation of antifungal targets and its use for molecular modelling in drug design","volume":"26","author":"Ruge","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.sbi.2008.07.006_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.chembiol.2007.03.015","article-title":"Structure of Saccharomyces cerevisiae Chitinase 1 and screening-based discovery of potent inhibitors","volume":"14","author":"Hurtado-Guerrero","year":"2007","journal-title":"Chem Biol"},{"key":"10.1016\/j.sbi.2008.07.006_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcv.2005.09.002","article-title":"Avian influenza A (H5N1)","volume":"35","author":"de Jong","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.sbi.2008.07.006_bib20_1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrd2400","article-title":"The war against influenza: discovery and development of sialidase inhibitors","volume":"6","author":"von Itzstein","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.sbi.2008.07.006_bib21","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/jmv.20951","article-title":"Neuraminidase inhibitor resistance in influenza viruses","volume":"79","author":"Reece","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.sbi.2008.07.006_bib22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3201\/eid1309.070111","article-title":"Detecting human-to-human transmission of avian influenza A (H5N1)","volume":"13","author":"Yang","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.sbi.2008.07.006_bib23","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nature06956","article-title":"Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants","volume":"453","author":"Collins","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2008.07.006_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cbpa.2008.01.036","article-title":"Avian influenza virus, a very sticky situation","volume":"12","author":"von Itzstein","year":"2008","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.sbi.2008.07.006_bib25","series-title":"Comprehensive Glycoscience","first-page":"885","article-title":"Design and synthesis of sialidase inhibitors for influenza virus infections","author":"Rich","year":"2007"},{"key":"10.1016\/j.sbi.2008.07.006_bib26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2217\/17460794.1.5.577","article-title":"Antiviral drugs for influenza: Tamiflu\u00ae past, present and future","volume":"1","author":"Laver","year":"2006","journal-title":"Future Virol"},{"key":"10.1016\/j.sbi.2008.07.006_bib27_1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature05264","article-title":"Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors","volume":"444","author":"Yamada","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2008.07.006_bib28_1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.1124513","article-title":"Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus","volume":"312","author":"Stevens","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.sbi.2008.07.006_bib29_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nm1529","article-title":"Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract","volume":"13","author":"Nicholls","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.sbi.2008.07.006_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tim.2008.01.008","article-title":"Evolving complexities of influenza virus and its receptors","volume":"16","author":"Nicholls","year":"2008","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.sbi.2008.07.006_bib31_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0076-6879(06)16002-4","article-title":"NMR analysis of carbohydrate\u2013protein interactions","volume":"416","author":"Angulo","year":"2006","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.sbi.2008.07.006_bib32","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.bbrc.2007.05.204","article-title":"Direct detection of ligand binding to Sepharose-immobilised protein using saturation transfer double difference (STDD) NMR spectroscopy","volume":"359","author":"Haselhorst","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.sbi.2008.07.006_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/glycob\/cwl051","article-title":"STD NMR spectroscopy and molecular modeling investigation of the binding of N-acetylneuraminic acid derivatives to rhesus rotavirus VP8* core","volume":"17","author":"Haselhorst","year":"2007","journal-title":"Glycobiol"},{"key":"10.1016\/j.sbi.2008.07.006_bib34","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/anie.200704872","article-title":"An investigation of avian influenza H5-containing virus-like particles (VLPs) host-cell receptor specificity by STD NMR spectroscopy","volume":"47","author":"Haselhorst","year":"2008","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.sbi.2008.07.006_bib35_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2008.07.006_bib36","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1021\/ja0723535","article-title":"Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design","volume":"129","author":"Amaro","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.sbi.2008.07.006_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10719-006-5435-y","article-title":"Role of sialic acids in rotavirus infection","volume":"23","author":"Isa","year":"2006","journal-title":"Glycoconj J"},{"key":"10.1016\/j.sbi.2008.07.006_bib38","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1128\/JVI.00597-08","article-title":"Rotavirus infection accelerates type 1 diabetes in mice with established insulitis","volume":"82","author":"Graham","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.sbi.2008.07.006_bib39","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1107\/S1744309105032999","article-title":"Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the VP8* carbohydrate-binding protein of the human rotavirus strain Wa","volume":"61","author":"Kraschnefski","year":"2005","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"10.1016\/j.sbi.2008.07.006_bib40","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jmb.2007.01.028","article-title":"Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*)","volume":"367","author":"Blanchard","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.sbi.2008.07.006_bib41","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1128\/JVI.80.3.1513-1523.2006","article-title":"High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain","volume":"80","author":"Monnier","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.sbi.2008.07.006_bib42","series-title":"Fundamental Virology","first-page":"577","article-title":"Paramyxoviridae: the viruses and their replication","author":"Lamb","year":"1996"},{"key":"10.1016\/j.sbi.2008.07.006_bib43","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1128\/AAC.48.5.1495-1502.2004","article-title":"Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo","volume":"48","author":"Alymova","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.sbi.2008.07.006_bib44_1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bmcl.2006.12.105","article-title":"Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity","volume":"17","author":"Tindal","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.sbi.2008.07.006_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10719-006-5446-8","article-title":"Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus","volume":"23","author":"Ryan","year":"2006","journal-title":"Glycoconj J"},{"key":"10.1016\/j.sbi.2008.07.006_bib46","first-page":"430","article-title":"Discovery of fructose-1,6-bisphosphatase inhibitors for the treatment of type 2 diabetes","volume":"10","author":"van Poelje","year":"2007","journal-title":"Curr Opin Drug Discov Dev"},{"key":"10.1016\/j.sbi.2008.07.006_bib47","doi-asserted-by":"crossref","first-page":"15491","DOI":"10.1021\/ja074871l","article-title":"Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes","volume":"129","author":"Dang","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.sbi.2008.07.006_bib48","doi-asserted-by":"crossref","first-page":"15480","DOI":"10.1021\/ja074869u","article-title":"Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity","volume":"129","author":"Erion","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.sbi.2008.07.006_bib49","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1517\/14728222.11.11.1473","article-title":"Targeting selectins and selectin ligands in inflammation and cancer","volume":"11","author":"Barthel","year":"2007","journal-title":"Exp Opin Ther Targets"},{"key":"10.1016\/j.sbi.2008.07.006_bib50","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/anie.200604442","article-title":"Synthetic glycopeptides from the E-selectin ligand 1 with varied sialyl Lewis(x) structure as cell-adhesion inhibitors of E-selectin","volume":"46","author":"Filser","year":"2007","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.sbi.2008.07.006_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1021\/jm0602256","article-title":"Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists","volume":"50","author":"Kaila","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.sbi.2008.07.006_bib52","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/jm060536g","article-title":"Rational design of novel, potent small molecule pan-selectin antagonists","volume":"50","author":"Kranich","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.sbi.2008.07.006_bib53","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1073\/pnas.0711491105","article-title":"Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB","volume":"105","author":"Ficko-Blean","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sbi.2008.07.006_bib54","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1074\/jbc.M705005200","article-title":"Crystal structures of complexes of N-butyl and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease","volume":"282","author":"Brumshtein","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.sbi.2008.07.006_bib55","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bmc.2007.09.036","article-title":"Discovery of novel alpha-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure","volume":"16","author":"Park","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.sbi.2008.07.006_bib56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.sbi.2008.07.006_bib57","unstructured":"Yang RY, Rabinovich GA, Liu FT: Galectins: structure, function and therapeutic potential. Exp Rev Mol Med 2008, in press, doi:10.1017\/S146239940800071."},{"key":"10.1016\/j.sbi.2008.07.006_bib58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jmb.2007.10.009","article-title":"Structural implications of Siglec-5-mediated sialoglycan recognition","volume":"375","author":"Zhuravleva","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.sbi.2008.07.006_bib59","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.jmb.2006.10.084","article-title":"Crystallographic and in silico analysis of the sialoside-binding characteristics of the Siglec sialoadhesin","volume":"365","author":"Zaccai","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.sbi.2008.07.006_bib60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/BJ20060103","article-title":"The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design","volume":"397","author":"Attrill","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.sbi.2008.07.006_bib61","doi-asserted-by":"crossref","first-page":"32774","DOI":"10.1074\/jbc.M601714200","article-title":"Siglec-7 undergoes a major conformational change when complexed with the \u03b1(2,8)-disialylganglioside GT1b","volume":"281","author":"Attrill","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.sbi.2008.07.006_bib62","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ab.2008.04.023","article-title":"Assessing the inhibitory potency of galectin ligands identified from combinatorial (glyco)peptide libraries using surface plasmon resonance spectroscopy","volume":"378","author":"Maljaars","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1016\/j.sbi.2008.07.006_bib63","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1021\/jm701266y","article-title":"Arginine binding motifs: design and synthesis of galactose-derived arginine tweezers as galectin-3 inhibitors","volume":"51","author":"Oberg","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.sbi.2008.07.006_bib64","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.carres.2007.03.012","article-title":"Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors","volume":"342","author":"Tejler","year":"2007","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.sbi.2008.07.006_bib65","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.bmcl.2008.05.066","article-title":"Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8","volume":"18","author":"Oberg","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.sbi.2008.07.006_bib66","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1107\/S1744309107050142","article-title":"Crystallization and preliminary crystallographic analysis of recombinant human galectin-1","volume":"63","author":"Scott","year":"2007","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"10.1016\/j.sbi.2008.07.006_bib67","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1107\/S090744490605270X","article-title":"Slow diffusion of lactose out of galectin-3 crystals monitored by X-ray crystallography: possible implications for ligand-exchange protocols","volume":"63","author":"Collins","year":"2007","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.sbi.2008.07.006_bib68","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/glycob\/cwm026","article-title":"Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface","volume":"17","author":"Carlsson","year":"2007","journal-title":"Glycobiology"},{"key":"10.1016\/j.sbi.2008.07.006_bib69","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1023\/A:1023813504011","article-title":"A visualisation aid for structure-based drug design","volume":"16","author":"Hartshorn","year":"2002","journal-title":"J Comput Aided Mol Des"}],"container-title":["Current Opinion in Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X08001218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X08001218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T23:29:51Z","timestamp":1545780591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959440X08001218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0959440X08001218"],"URL":"https:\/\/doi.org\/10.1016\/j.sbi.2008.07.006","relation":{},"ISSN":["0959-440X"],"issn-type":[{"value":"0959-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}